FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079758246> ?p ?o ?g. }

• W2079758246 endingPage "218" @default.
• W2079758246 startingPage "212" @default.
• W2079758246 abstract "Background Diabetes is an important determinant of prognosis in patients with ST-segment elevation myocardial infarction (STEMI). Limited data are available concerning benefits and risks of upstream abciximab administration in diabetic patients. Thus, the objective of the study was to assess the impact of early abciximab administration before primary angioplasty (PCI) for STEMI in diabetic patients. Methods Data were gathered for 1650 consecutive STEMI patients transferred for primary PCI from hospital networks in seven countries in Europe from November 2005 to January 2007 (the EUROTRANSFER Registry population). Patients were stratified by diabetes mellitus presence and then by abciximab administration strategy (early – more than 30 min before PCI vs. late). Results Diabetes mellitus was diagnosed in 262 (15.9%) patients. Patients with diabetes mellitus were high-risk individuals, with advanced age, higher prevalence of comorbidities and increased risk of ischemic events during follow-up in comparison to non-diabetic patients. A total of 1086 patients who received abciximab were identified. Strategy of early abciximab administration was associated with enhanced infarct-related artery patency before PCI, and improved epicardial flow after PCI in both diabetic and non-diabetic patients. Importantly, early abciximab in diabetic patients led to the decrease in ischemic events, including 30-day (OR 0.260, 95% CI 0.089–0.759, p = 0.012) and 1-year (OR 0.273, 95% CI 0.099–0.749, p = 0.012) mortality reduction. However, only a trend toward improved survival was confirmed after adjustment for potential confounders. On the contrary, the reduction of 30-day (OR 0.620, 95% CI 0.334–1.189, p = 0.16) and 1-year (OR 0.643, 95% CI 0.379–1.089, p = 0.10) mortality rates was not significant among non-diabetic patients. Conclusions Early administration of abciximab improves infarct-related artery patency before and after primary PCI, and leads to improved survival in diabetic STEMI patients." @default.
• W2079758246 created "2016-06-24" @default.
• W2079758246 creator A5005355829 @default.
• W2079758246 creator A5021516595 @default.
• W2079758246 creator A5027497836 @default.
• W2079758246 creator A5036197968 @default.
• W2079758246 creator A5038328891 @default.
• W2079758246 creator A5043882797 @default.
• W2079758246 creator A5058539268 @default.
• W2079758246 creator A5071539074 @default.
• W2079758246 creator A5074096971 @default.
• W2079758246 date "2012-07-01" @default.
• W2079758246 modified "2023-09-24" @default.
• W2079758246 title "Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry)" @default.
• W2079758246 cites W107577559 @default.
• W2079758246 cites W1530526916 @default.
• W2079758246 cites W1540597915 @default.
• W2079758246 cites W1967234746 @default.
• W2079758246 cites W1970640054 @default.
• W2079758246 cites W1973267148 @default.
• W2079758246 cites W1974987798 @default.
• W2079758246 cites W1983567586 @default.
• W2079758246 cites W1985284980 @default.
• W2079758246 cites W1995069461 @default.
• W2079758246 cites W2003914920 @default.
• W2079758246 cites W2015906285 @default.
• W2079758246 cites W2020099275 @default.
• W2079758246 cites W2021970054 @default.
• W2079758246 cites W2032167693 @default.
• W2079758246 cites W2041301600 @default.
• W2079758246 cites W2051288819 @default.
• W2079758246 cites W2067224489 @default.
• W2079758246 cites W2070589757 @default.
• W2079758246 cites W2076916461 @default.
• W2079758246 cites W2081799397 @default.
• W2079758246 cites W2085413583 @default.
• W2079758246 cites W2097646648 @default.
• W2079758246 cites W2103694166 @default.
• W2079758246 cites W2109446643 @default.
• W2079758246 cites W2110475057 @default.
• W2079758246 cites W2121690051 @default.
• W2079758246 cites W2131184211 @default.
• W2079758246 cites W2138058610 @default.
• W2079758246 cites W2139834809 @default.
• W2079758246 cites W2140387401 @default.
• W2079758246 cites W2143160122 @default.
• W2079758246 cites W2150086052 @default.
• W2079758246 cites W2152193032 @default.
• W2079758246 cites W2154421193 @default.
• W2079758246 cites W2157123954 @default.
• W2079758246 cites W2172272070 @default.
• W2079758246 cites W2206833555 @default.
• W2079758246 cites W2333133657 @default.
• W2079758246 cites W2427637677 @default.
• W2079758246 cites W2568050971 @default.
• W2079758246 cites W2887768525 @default.
• W2079758246 cites W3209376675 @default.
• W2079758246 cites W1888457831 @default.
• W2079758246 doi "https://doi.org/10.1016/j.atherosclerosis.2012.04.018" @default.
• W2079758246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22658254" @default.
• W2079758246 hasPublicationYear "2012" @default.
• W2079758246 type Work @default.
• W2079758246 sameAs 2079758246 @default.
• W2079758246 citedByCount "7" @default.
• W2079758246 countsByYear W20797582462012 @default.
• W2079758246 countsByYear W20797582462014 @default.
• W2079758246 countsByYear W20797582462015 @default.
• W2079758246 countsByYear W20797582462017 @default.
• W2079758246 countsByYear W20797582462022 @default.
• W2079758246 crossrefType "journal-article" @default.
• W2079758246 hasAuthorship W2079758246A5005355829 @default.
• W2079758246 hasAuthorship W2079758246A5021516595 @default.
• W2079758246 hasAuthorship W2079758246A5027497836 @default.
• W2079758246 hasAuthorship W2079758246A5036197968 @default.
• W2079758246 hasAuthorship W2079758246A5038328891 @default.
• W2079758246 hasAuthorship W2079758246A5043882797 @default.
• W2079758246 hasAuthorship W2079758246A5058539268 @default.
• W2079758246 hasAuthorship W2079758246A5071539074 @default.
• W2079758246 hasAuthorship W2079758246A5074096971 @default.
• W2079758246 hasConcept C126322002 @default.
• W2079758246 hasConcept C134018914 @default.
• W2079758246 hasConcept C164705383 @default.
• W2079758246 hasConcept C2777871224 @default.
• W2079758246 hasConcept C2780326628 @default.
• W2079758246 hasConcept C2780400711 @default.
• W2079758246 hasConcept C2908647359 @default.
• W2079758246 hasConcept C45393284 @default.
• W2079758246 hasConcept C500558357 @default.
• W2079758246 hasConcept C555293320 @default.
• W2079758246 hasConcept C71924100 @default.
• W2079758246 hasConcept C99454951 @default.
• W2079758246 hasConceptScore W2079758246C126322002 @default.
• W2079758246 hasConceptScore W2079758246C134018914 @default.
• W2079758246 hasConceptScore W2079758246C164705383 @default.
• W2079758246 hasConceptScore W2079758246C2777871224 @default.
• W2079758246 hasConceptScore W2079758246C2780326628 @default.
• W2079758246 hasConceptScore W2079758246C2780400711 @default.
• W2079758246 hasConceptScore W2079758246C2908647359 @default.

• next